Author:
Guglielmetti Lorenzo,Robert Horsburgh C.
Publisher
Springer Nature Singapore
Reference48 articles.
1. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications. Internaional Journal of Tuberculosis and Lung Disease. 1999;3:S231–79.
2. Fregonese F, Ahuja SD, Akkerman OW, Arakaki-Sanchez D, Ayakaka I, Baghaei P, Bang D, Bastos M, Benedetti A, Bonnet M, Cattamanchi A, Cegielski P, Chien J-Y, Cox H, Dedicoat M, Erkens C, Escalante P, Falzon D, Garcia-Prats AJ, Gegia M, Gillespie SH, Glynn JR, Goldberg S, Griffith D, Jacobson KR, Johnston JC, Jones-López EC, Khan A, Koh W-J, Kritski A, et al. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respir Med. 2018;6:265–75.
3. Gegia M, Winters N, Benedetti A, van Soolingen D, Menzies D. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17:223–34.
4. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4, Module 4, [Internet]. 2020 [cited 2020 Dec 27].Available from: http://www.ncbi.nlm.nih.gov/books/NBK558570/.
5. Guglielmetti L, Huerga H, Khan U, Varaine F. WHO 2019 guidelines on drug-resistant tuberculosis treatment: based on evidence or expert opinion? Eur Respir J. 2020;55:1901935.